Investigation Overview
San Diego, Jan. 25, 2012 (Shareholders Foundation) -- The announcement by Roche that it intends to acquire all outstanding shares of Illumina, Inc. (NASDAQ:ILMN) for $44.50 per share prompted an investigation for investors in Illumina (ILMN) shares concerning whether the offer to acquire Illumina Inc. and the buyout process are unfair to investors in NASDAQ:ILMN). The investigations ...
You must register (for free) or login to view the entire investigation.